Clinical Trials Browser

Phase 3 × Aromatase Inhibitors × 90 days × Clear all

NCT05879926 2026-03-03

OFSET

Phase 3 Recruiting

Breast Neoplasms

NCT02767661 2026-02-27

MECCA

Phase 3 Completed

Breast Neoplasms

NCT07400523 2026-02-10

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Not yet recruiting

Breast Neoplasms